Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View Item
  • Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Assessing response to treatment in breast cancer using magnetic resonance.

Thumbnail
Publication Date
2002-09
ICR Author
Leach, Martin
Author
Leach, MO
Type
Journal Article
Metadata
Show full item record
Abstract
Magnetic resonance imaging provides a range of powerful techniques for assessing breast cancer. Contrast enhanced MRI has been shown to provide a sensitive method for assessing primary breast cancer, with increasing emphasis on performing dynamic analysis, and using quantitative analysis techniques. Magnetic resonance spectroscopy provides information on tumour metabolism and has been investigated as a method of assessing response to therapy. The response of metastatic disease from bone cancer has been assessed using T1 weighted methods. MRI provides information on response to treatment early in the course of chemotherapy. Following chemotherapy it provides a sensitive method of assessing residual disease. Both, with conventional treatments and with new antiangiogenic, antivascular and cytostatic treatments, there is a growing role for functional methods of assessing tumour response to treatment.
URL
https://repository.icr.ac.uk/handle/internal/2221
Collections
  • Radiotherapy and Imaging
Subject
Humans
Bone Neoplasms
Breast Neoplasms
Disease Progression
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Female
Clinical Trials as Topic
Research team
Magnetic Resonance
Language
eng
License start date
2002-09
Citation
Journal of experimental & clinical cancer research : CR, 2002, 21 (3 Suppl), pp. 39 - 45

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.